Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Vagus nerve stimulation to help recovery after cervical spine decompression

Official title: Vagus Nerve Stimulation to Improve Post-operative Outcomes of Degenerative Cervical Myelopathy

Run by Washington University School of Medicine · NCT07660250 · Data updated 2026-11-12

This study tests whether transauricular vagus nerve stimulation can help people with moderate to severe degenerative cervical myelopathy recover better after decompression surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment36 (estimated)
SponsorWashington University School of Medicine
Academic / other
Locations1 site (St Louis, Missouri)
StatusRecruiting
StartedApril 14, 2026
Main results expectedApril 2028
Study endsMay 2028
Registry record updatedJune 22, 2026
Trial IDNCT07660250 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with moderate to severe degenerative cervical myelopathy planning decompression surgery.

Probably not a fit

Patients with certain comorbid conditions or prior cervical spine surgery may not experience benefit from taVNS.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study explores the feasibility and potential effectiveness of transauricular vagus nerve stimulation (taVNS) added to the standard care for adults with moderate to severe degenerative cervical myelopathy who are planning decompression surgery. Participants are randomized to receive taVNS or sham stimulation around the time of surgery to see if the approach improves postoperative outcomes. The trial aims to generate preliminary data on safety, tolerability, and signals of clinical benefit. Eligible participants are adults with moderate or severe DCM without certain comorbid conditions and who are undergoing decompression surgery at Washington University in St. Louis.

Why it matters

Potential benefit: If successful, taVNS could improve functional recovery after decompression surgery for degenerative cervical myelopathy.

How similar studies have gone: Previous work in neuromodulation has shown signals of functional improvement in related conditions, but this specific taVNS approach for DCM is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years of age or older
* Moderate or severe degenerative cervical myelopathy according to the mJOA
* Decompression surgery planned

Exclusion Criteria:

* • Pregnancy

  * Electrically active implants (e.g. pacemaker)
  * Known diagnosis of amyotrophic lateral sclerosis, multiple sclerosis, rheumatoid arthritis, concomitant thoracic and/or lumbar stenosis, spine tumor, HIV-related myelopathy
  * Ongoing cancer therapy
  * Ongoing use of immunomodulating or suppressive medication
  * Sustained bradycardia with a heartrate \<50 beats per minute for \> 5 minutes following admission.
  * Prior cervical spine surgery

Where it's running

  • Washington University
    St Louis, Missouri, United States
    Recruiting

Study contacts

  • Principal investigator: Wilson Z Ray, MD — Washington University School of Medicine
  • Study coordinator: Linda Koester, BS
  • Email: koesterl@wustl.edu
  • Phone: 314-362-7368

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.